AC Immune (ACIU) Long-Term Debt Issuances (2017 - 2019)
AC Immune (ACIU) posted quarterly Long-Term Debt Issuances of -$50.6 million for Q4 2019, down 100811.09% year-over-year from N/an in Q4 2018, and down 200.23% quarter-over-quarter from $50.5 million in Q1 2019.
AC Immune (ACIU) Long-Term Debt Issuances (2017 - 2019) Analysis & Trends
AC Immune (ACIU) has reported Long-Term Debt Issuances for 3 consecutive years, with -$50.6 million the latest figure, recorded in Q4 2019.
- In Q4 2019, Long-Term Debt Issuances fell 100811.09% year-over-year to -$50.6 million; the TTM figure through Dec 2019 stood at -$116746.2 (down 104.21% YoY), while the FY2021 annual figure was $25.7 million, changed N/A from the prior year.
- Long-Term Debt Issuances retreated to -$50.6 million in Q4 2019 per ACIU's latest filing, from $50.5 million in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $103.9 million in Q3 2017 and bottomed at -$101.2 million in Q4 2017.
- Historically, Long-Term Debt Issuances has averaged $531074.0 across 3 years, with a median of $50241.7 in 2018.
- Annual changes were most pronounced in 2018 — Long-Term Debt Issuances jumped 100.05% — and 2019, when it sank 100811.09%.
- AC Immune's Long-Term Debt Issuances stood at -$101.2 million in 2017, then surged by 100.05% to $50241.7 in 2018, then tumbled by 100811.09% to -$50.6 million in 2019.
- Business Quant data shows ACIU's Long-Term Debt Issuances at -$50.6 million in Q4 2019, $50.5 million in Q1 2019, and $50241.7 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -675,522.58 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | AC Immune | 253.89 Mn | 253.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -50.60 Mn |
| Dec 31, 2019 | -50.60 Mn |
| Mar 31, 2019 | 50.48 Mn |
| Mar 31, 2019 | 50.48 Mn |
| Dec 31, 2018 | 50,241.74 |
| Dec 31, 2018 | 50,241.74 |
| Dec 31, 2017 | -101.16 Mn |
| Dec 31, 2017 | -101.16 Mn |
| Sep 30, 2017 | 103.88 Mn |
| Sep 30, 2017 | 103.88 Mn |